{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:04:24Z","timestamp":1790723064995,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T00:00:00Z","timestamp":1258416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T00:00:00Z","timestamp":1258416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/mp.2009.121","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T09:02:16Z","timestamp":1258448536000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["1H-MRS at 4 Tesla in minimally treated early schizophrenia"],"prefix":"10.1038","volume":"15","author":[{"given":"J R","family":"Bustillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Qualls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W M","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,17]]},"reference":[{"key":"BFmp2009121_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB . Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52: 998\u20131007.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2009121_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0006-3223(95)00046-1","volume":"38","author":"NB Farber","year":"1995","unstructured":"Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St Peter H et al. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia. Biol Psychiatry 1995; 38: 788\u2013796.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009121_CR3","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1992","unstructured":"Moghaddam B, Adams B, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway for NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1992; 17: 2921\u20132927.","journal-title":"J Neurosci"},{"key":"BFmp2009121_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.schres.2004.02.003","volume":"73","author":"LM Reynolds","year":"2005","unstructured":"Reynolds LM, Cochran SM, Morris BJ, Pratt JA, Reynolds GP . Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartylglutamate in rat brain. Schizophr Res 2005; 73: 147\u2013152.","journal-title":"Schizophr Res"},{"key":"BFmp2009121_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hipo.1069","volume":"11","author":"JW Newcomer","year":"2001","unstructured":"Newcomer JW, Krystal JH . NMDA receptor regulation of memory and behavior in humans. Hippocampus 2001; 11: 529\u2013542.","journal-title":"Hippocampus"},{"key":"BFmp2009121_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","volume":"162","author":"L Rowland","year":"2005","unstructured":"Rowland L, Bustillo J, Mullins P, Jung R, Lenroot R, Landgraf E et al. The effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4.0T proton MRS study. Am J Psychiatry 2005; 162: 394\u2013396.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009121_CR7","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","volume":"159","author":"J Theberge","year":"2002","unstructured":"Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J et al. Glutamate and glutamine measured with 4.0T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 2002; 159: 1944\u20131946.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009121_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.biopsych.2007.05.025","volume":"62","author":"L Chang","year":"2007","unstructured":"Chang L, Friedman J, Ernst T, Zhong K, Tsopelas ND, Davis K . Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry 2007; 62: 1396\u20131404.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009121_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-244X-5-6","volume":"5","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstr\u00f6m LH, Iyo M . Elevated glutamine\/glutamate ratio in cerebrospinal fluid of first episode and drug na\u00efve schizophrenic patients. BMC Psychiatry 2005; 5: 6.","journal-title":"BMC Psychiatry"},{"key":"BFmp2009121_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.npp.1300874","volume":"31","author":"J Bustillo","year":"2006","unstructured":"Bustillo J, Barrow R, Paz R, Tang J, Seraji-Bozorgzad N, Moore G et al. Long term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology 2006; 31: 751\u2013756.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2009121_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/1522-2594(200008)44:2<185::AID-MRM4>3.0.CO;2-V","volume":"44","author":"R Bartha","year":"2000","unstructured":"Bartha R, Drost DJ, Menon RS, Williamson PC . Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 2000; 44: 185\u2013192.","journal-title":"Magn Reson Med"},{"key":"BFmp2009121_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.0.CO;2-P","volume":"40","author":"WM Brooks","year":"1999","unstructured":"Brooks WM, Friedman SD, Stidley CA . Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999; 40: 193\u2013197.","journal-title":"Magn Reson Med"},{"key":"BFmp2009121_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/(SICI)1522-2586(199901)9:1<39::AID-JMRI5>3.0.CO;2-8","volume":"9","author":"H Petropoulos","year":"1999","unstructured":"Petropoulos H, Sibbitt Jr WL, Brooks WM . Automated T2 quantitation in neuropsychiatric lupus erythematosus: a marker of active disease. J Magn Reson Imaging 1999; 9: 39\u201343.","journal-title":"J Magn Reson Imaging"},{"key":"BFmp2009121_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jmrb.1993.1055","volume":"102","author":"T Ernst","year":"1993","unstructured":"Ernst T, Kreis R, Ross BD . Absolute quantitation of water and metabolites in the human brain. 1. Compartments and water. J Magn Reson B 1993; 102: 1\u20138.","journal-title":"J Magn Reson B"},{"key":"BFmp2009121_CR15","unstructured":"Andreasen NC . Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City, 1984."},{"key":"BFmp2009121_CR16","unstructured":"Andreasen NC . Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City, 1984."},{"key":"BFmp2009121_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JW . A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212: 11\u201319.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"BFmp2009121_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TR Barnes","year":"1989","unstructured":"Barnes TR . A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672\u2013676.","journal-title":"Br J Psychiatry"},{"key":"BFmp2009121_CR19","doi-asserted-by":"crossref","unstructured":"Guy W . ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. US Department of Health, Education and Welfare: Washington, DC, 1976 pp 534\u2013537.","DOI":"10.1037\/e591322011-001"},{"key":"BFmp2009121_CR20","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","volume":"30","author":"RG Steen","year":"2005","unstructured":"Steen RG, Hamer RM, Lieberman JA . Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005; 30: 1949\u20131962.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2009121_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/(SICI)1522-2594(200003)43:3<355::AID-MRM6>3.0.CO;2-R","volume":"43","author":"DM Lindquist","year":"2000","unstructured":"Lindquist DM, Hawk RM, Karson CN, Komoroski RA . Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magn Reson Med 2000; 43: 355\u2013358.","journal-title":"Magn Reson Med"},{"key":"BFmp2009121_CR22","first-page":"1","volume":"1889","author":"J Bustillo","year":"2002","unstructured":"Bustillo J, Wolff C, Myers-Gutierrez A, Dettmer T, Cooper T, Allan A et al. Treatment of rats with antipsychotic drugs: lack of an effect on N acetyl-aspartate levels. Schizophr Res 2002; 1889: 1\u20139.","journal-title":"Schizophr Res"},{"key":"BFmp2009121_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1098\/rstb.1999.0471","volume":"354","author":"PJ Magistretti","year":"1999","unstructured":"Magistretti PJ, Pellerin L . Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Phil Trans R Soc Lond 1999; 354: 1155\u20131163.","journal-title":"Phil Trans R Soc Lond"},{"key":"BFmp2009121_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.neuroimage.2005.06.016","volume":"28","author":"S Xu","year":"2005","unstructured":"Xu S, Yang J, Li C, Zhu W, Shen J . Metabolic alterations in focally activated primary somatosensory cortex of alpha-chloralose-anesthetized rats measured by H MRS at 11.7T. Neuroimage 2005; 28: 401\u2013409.","journal-title":"Neuroimage"},{"key":"BFmp2009121_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1176\/appi.ajp.161.6.1116","volume":"161","author":"P Tibbo","year":"2004","unstructured":"Tibbo P, Hanstock C, Valiakalayil A, Allen P . 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. Am J Psychiatry 2004; 161: 1116\u20131118.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009121_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.biopsych.2005.04.041","volume":"58","author":"L Tebartz van Elst","year":"2005","unstructured":"Tebartz van Elst L, Valerius G, Buchert M, Thiel T, Rusch N, Bubl E et al. Increased prefrontal and hippocampal glutamate and concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 2005; 58: 724\u2013730.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009121_CR27","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","volume":"160","author":"J Theberge","year":"2003","unstructured":"Theberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 2003; 160: 2231\u20132233.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009121_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00004424-199606000-00006","volume":"6","author":"BY Choe","year":"1996","unstructured":"Choe BY, Suh TS, Shinn KS, Lee CW, Lee C, Paik IH . Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest Radiol 1996; 6: 345\u2013352.","journal-title":"Invest Radiol"},{"key":"BFmp2009121_CR29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0006-3223(03)00185-9","volume":"54","author":"D Fannon","year":"2003","unstructured":"Fannon D, Simmons A, Tennakoon L, O'Ceallaiagh S, Sumich A, Doku V et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-na\u00efve patients with schizophrenia. Biol Psychiatry 2003; 54: 587\u2013598.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009121_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0920-9964(02)00210-4","volume":"58","author":"J Bustillo","year":"2002","unstructured":"Bustillo J, Lauriello J, Rowland L, Thomson L, Petropoulus H, Hammond R et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr Res 2002; 58: 313\u2013321.","journal-title":"Schizophr Res"},{"key":"BFmp2009121_CR31","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1038\/sj.npp.1301631","volume":"33","author":"J Bustillo","year":"2008","unstructured":"Bustillo J, Rowland L, Jung R, Brooks W, Qualls C, Hammond R et al. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. Neuropsychopharmacology 2008; 33: 2456\u20132466.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2009121_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","volume":"191","author":"J Theberge","year":"2007","unstructured":"Theberge J, Williamson KE, Aoyama N, Drost DJ, Manchanda R, Malla AK et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry 2007; 191: 325\u2013334.","journal-title":"Br J Psychiatry"},{"key":"BFmp2009121_CR33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1176\/ajp.154.6.861","volume":"154","author":"RJ Baldessarini","year":"1997","unstructured":"Baldessarini RJ, Hegarty JD, Bird ED, Benes FM . Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am J Psychiatry 1997; 154: 861\u2013863.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009121_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","volume":"57","author":"L Glantz","year":"2000","unstructured":"Glantz L, Lewis D . Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65\u201373.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2009121_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1148\/radiol.2352040003","volume":"235","author":"M Lentz","year":"2005","unstructured":"Lentz M, Kim J, Westmoreland S, Greco J, Fuller R, Ratai E et al. Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. Radiology 2005; 235: 461\u2013468.","journal-title":"Radiology"},{"key":"BFmp2009121_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.biopsych.2006.03.015","volume":"60","author":"T Hajszan","year":"2006","unstructured":"Hajszan T, Leranth C, Roth RH . Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex. Biol Psychiatry 2006; 60: 639\u2013644.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009121_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/glia.20119","volume":"49","author":"C Matute","year":"2005","unstructured":"Matute C, Melone M, Vallejo-Illarramendi A, Conti F . Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics. Glia 2005; 49: 451\u2013455.","journal-title":"Glia"},{"key":"BFmp2009121_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1176\/appi.ajp.159.7.1165","volume":"159","author":"MR Gluck","year":"2002","unstructured":"Gluck MR, Thomas RG, Davis KL, Haroutunian V . Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 2002; 159: 1165\u20131173.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009121_CR39","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/sj.npp.1301356","volume":"32","author":"X L\u00f3pez-Gil","year":"2007","unstructured":"L\u00f3pez-Gil X, Babot Z, Amarg\u00f3s-Bosch M, Su\u00f1ol C, Artigas F, Adell A . Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. Neuropsychopharmacology 2007; 32: 2087\u20132097.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2009121_CR40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1001\/archpsyc.55.4.346","volume":"55","author":"KO Lim","year":"1998","unstructured":"Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pferfferbaum A . Proton magnetic resonance imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998; 55: 346\u2013352.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2009121_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0925-4927(99)00023-2","volume":"91","author":"A Pfefferbaum","year":"1999","unstructured":"Pfefferbaum A, Sullivan EV, Hedehus M, Moseley M, Lim KO . Brain gray and white matter transverse relaxation time in schizophrenia. Psychiatry Res 1999; 91: 93\u2013100.","journal-title":"Psychiatry Res"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2009121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2009121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2009121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:29:42Z","timestamp":1648780182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2009121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,17]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFmp2009121"],"URL":"https:\/\/doi.org\/10.1038\/mp.2009.121","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,17]]},"assertion":[{"value":"11 February 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}